Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study

被引:42
作者
Chen, Mu-Hong [1 ,2 ]
Li, Cheng-Ta [1 ,2 ,4 ]
Lin, Wei-Chen [2 ,4 ]
Hong, Chen-Jee [1 ,2 ,4 ]
Tu, Pei-Chi [1 ,2 ,3 ]
Bai, Ya-Mei [1 ,2 ]
Cheng, Chih-Ming [2 ]
Su, Tung-Ping [1 ,2 ,3 ,4 ,5 ]
机构
[1] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Psychiat, 201,Sec 2,Shih-Pai Rd, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan
[5] Gen Cheng Hsin Hosp, Dept Psychiat, Taipei, Taiwan
关键词
Ketamine; Treatment-resistant depression; PET; Supplementary motor area; Dorsal anterior cingulate cortex; UNIPOLAR DEPRESSION; RESIDUAL SYMPTOMS; PREFRONTAL CORTEX; PET SCANS; DISORDER; REMISSION; BRAIN; ADOLESCENTS; OUTCOMES; CARE;
D O I
10.1016/j.jad.2017.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A single low-dose ketamine infusion exhibited a rapid antidepressant effect within 1 h. Despite its short biological half-life (approximately 3 h), the antidepressant effect of ketamine has been demonstrated to persist for several days. However, changes in brain function responsible for the persistent antidepressant effect of a single low-dose ketamine infusion remain unclear Methods: Twenty-four patients with treatment-resistant depression (TRD) were randomized into three groups according to the treatment received: 0.5 mg/kg ketamine, 0.2 mg/kg ketamine, and normal saline infusion. Standardized uptake values (SUVs) of glucose metabolism measured through F-18-FDG positron-emission-tomography before infusion and 1 day after a 40-min ketamine or normal saline infusion were used for subsequent whole-brain voxel-wise analysis and were correlated with depressive symptoms, as defined using the Hamilton Depression Rating Scale-17 (HDRS-17) score Results: The voxel-wise analysis revealed that patients with TRD receiving the 0.5 mg/kg ketamine infusion had significantly higher SUVs (corrected for family-wise errors, P = 0.014) in the supplementary motor area (SMA) and dorsal anterior cingulate cortex (dACC) than did those receiving the 0.2 mg/kg ketamine infusion. The increase in the SUV in the dACC was negatively correlated with depressive symptoms at 1 day after ketamine infusion Discussion: The persistent antidepressant effect of a 0.5 mg/kg ketamine infusion may be mediated by increased activation in the SMA and dACC. The higher increase in dACC activation was related to the reduction in depressive symptoms after ketamine infusion. A 0.5 mg/kg ketamine infusion facilitated the glutamatergic neurotransmission in the SMA and dACC, which may be responsible for the persistent antidepressant effect of ketamine much beyond its half-life.
引用
收藏
页码:709 / 714
页数:6
相关论文
共 38 条
  • [1] KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
    Abdallah, Chadi G.
    Adams, Thomas G.
    Kelmendi, Benjamin
    Esterlis, Irina
    Sanacora, Gerard
    Krystal, John H.
    [J]. DEPRESSION AND ANXIETY, 2016, 33 (08) : 689 - 697
  • [2] HF-rTMS Treatment in Medication-Resistant Melancholic Depression: Results from 18FDG-PET Brain Imaging
    Baeken, Chris
    De Raedt, Rudi
    Van Hove, Christian
    Clerinx, Peter
    De Mey, Johan
    Bossuyt, Axel
    [J]. CNS SPECTRUMS, 2009, 14 (08) : 439 - 448
  • [3] Cognitive and emotional influences in anterior cingulate cortex
    Bush, G
    Luu, P
    Posner, MI
    [J]. TRENDS IN COGNITIVE SCIENCES, 2000, 4 (06) : 215 - 222
  • [4] Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
    Carlson, Paul J.
    Diazgranados, Nancy
    Nugent, Allison C.
    Ibrahim, Lobna
    Luckenbaugh, David A.
    Brutsche, Nancy
    Herscovitch, Peter
    Manji, Husseini K.
    Zarate, Carlos A., Jr.
    Drevets, Wayne C.
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (12) : 1213 - 1221
  • [5] Neurostimulation as an intervention for treatment resistant depression: From research on mechanisms towards targeted neurocognitive strategies
    De Raedt, Rudi
    Vanderhasselt, Marie-Anne
    Baeken, Chris
    [J]. CLINICAL PSYCHOLOGY REVIEW, 2015, 41 : 61 - 69
  • [6] Dignam P, 2009, AUST NZ J PSYCHIAT, V43, P87
  • [7] Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
    Downey, Darragh
    Dutta, Arpan
    McKie, Shane
    Dawson, Gerard R.
    Dourish, Colin T.
    Craig, Kevin
    Smith, Mark A.
    McCarthy, Dennis J.
    Harmer, Catherine J.
    Goodwin, Guy M.
    Williams, Steve
    Deakin, J. F. William
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 994 - 1003
  • [8] What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies
    Fekadu, Abebaw
    Wooderson, Sarah C.
    Markopoulo, Kalypso
    Donaldson, Catherine
    Papadopoulos, Andrew
    Cleare, Anthony J.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 116 (1-2) : 4 - 11
  • [9] THE RELATIONSHIP BETWEEN GLOBAL AND LOCAL CHANGES IN PET SCANS
    FRISTON, KJ
    FRITH, CD
    LIDDLE, PF
    DOLAN, RJ
    LAMMERTSMA, AA
    FRACKOWIAK, RSJ
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1990, 10 (04) : 458 - 466
  • [10] Influence of the normalization template on the outcome of statistical parametric mapping of PET scans
    Gispert, JD
    Pascau, J
    Reig, S
    Martínez-Lázaro, R
    Molina, V
    García-Barreno, P
    Desco, M
    [J]. NEUROIMAGE, 2003, 19 (03) : 601 - 612